Concepedia

Lijie Zhao

LZ

Statistics

Publications

18

Citations

1.5K

H-Index

17

Active since

2014

Affiliations

University of Michigan(Current)

Zhengzhou University

Daqing Oilfield General Hospital

Howard Hughes Medical Institute

Michigan Center for Translational Pathology

Lijie Zhao is an author at University of Michigan specializing in pharmacology, drug discovery, and medicine.

Publications per year

2014–2024

18

Publications

18

Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer

Xin Han, Chao Wang, Chong Qin et al. · Journal of Medicinal Chemistry · 2019 · 381 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands

Xin Han, Lijie Zhao, Weiguo Xiang et al. · Journal of Medicinal Chemistry · 2019 · 212 citations · Full text

Medicine, Oncology, Pharmacology +15

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Weiguo Xiang, Lijie Zhao, Xin Han et al. · Journal of Medicinal Chemistry · 2021 · 140 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Xin Han, Lijie Zhao, Weiguo Xiang et al. · Journal of Medicinal Chemistry · 2021 · 137 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5-<i>a</i>]pyrimidine-Based Inhibitors Targeting the DCN1–UBC12 Protein–Protein Interaction

Shuai Wang, Shuai Wang, Lijie Zhao et al. · Journal of Medicinal Chemistry · 2019 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

1–5 of 18